| Net Cash Provided by (Used in) Financing Activities |
94.8K |
USD |
-53% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
-7.71K |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
350M |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
26.5M |
shares |
+45.5% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
384 |
USD |
+273% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
255 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
2.67M |
USD |
+73.1% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
2.67M |
USD |
+73.1% |
Q3 2025 |
Q1 2026 |
| Depreciation |
41.8K |
USD |
|
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
1.16M |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
7.02M |
USD |
|
Q2 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
624K |
USD |
|
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
9.47M |
USD |
+57.6% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
264K |
USD |
-3.27% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
54.6K |
USD |
+484% |
Q3 2025 |
Q1 2026 |